Literature DB >> 8923863

X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children.

M P Whyte1, F W Schranck, R Armamento-Villareal.   

Abstract

X-Linked hypophosphatemia (XLH) is a sex-linked dominant disorder. It is possible that females are more mildly affected than males. No information is available regarding other potential genetic influences on XLH expression in patients, such as race, anticipation, parent of origin, or molecular heterogeneity. We investigated the above potential genetic influences on XLH expressivity using data from 116 pediatric patients. To compare biochemical parameters, we used data from the 30 prepubertal children (23 girls and 7 boys) selected because they had been without medical therapy for at least 3 months (25 of 30 never treated). To compare height z-scores, we used data from the 27 patients (pre- or postpubertal) selected because they had never received medical or surgical treatment. Ascertainment bias (i.e. referral of girls who were severely affected) was not apparent (observed female/male ratio, 1.64; expected, 2.00; P = 0.29). Parameters of mineral homeostasis did not show statistically significant differences between girls vs. boys, sporadic vs. multigenerational cases (except lower fasting serum phosphate levels in sporadic cases; mean +/- SEM, 2.68 +/- 0.10 vs. 3.02 +/- 0.04 mg/dL; P = 0.049), blacks vs. whites, or for the girls for whom affected fathers vs. mothers transmitted the disorder. Height z-scores correlated with renal phosphate reclamation (i.e. tubular maximum of phosphorus/glomerular filtration rate; r = 0.68; P = 0.014), but were not different for the groupings above. Furthermore, we found no evidence for meiotic drive or for a parental age effect to explain the 18.3% of patients that were new mutations for XLH. Our data fail to show any evidence for genetic heterogeneity or for gender, race, anticipation, or parent of origin effects on XLH expression in children. Despite the recent discovery of a gene (PEX) that is mutated in XLH, the sex-linked dominant phenotype and apparent absence of a gene dose effect in XLH expression in children require explanation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923863     DOI: 10.1210/jcem.81.11.8923863

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.

Authors:  Y Yu; S R Sanderson; M Reyes; A Sharma; N Dunbar; T Srivastava; H Jüppner; C Bergwitz
Journal:  Bone       Date:  2012-02-24       Impact factor: 4.398

Review 3.  Clinical practice: diagnostic approach to the rachitic child.

Authors:  Jaishen Rajah; Kebashni Thandrayen; John M Pettifor
Journal:  Eur J Pediatr       Date:  2011-07-21       Impact factor: 3.183

4.  Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy.

Authors:  Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2015-10       Impact factor: 5.958

5.  Phenotypes of a family with XLH with a novel PHEX mutation.

Authors:  Akiko Yamamoto; Toshiro Nakamura; Yasuhisa Ohata; Takuo Kubota; Keiichi Ozono
Journal:  Hum Genome Var       Date:  2020-03-31

Review 6.  X-linked hypophosphatemia and growth.

Authors:  R Fuente; H Gil-Peña; D Claramunt-Taberner; O Hernández; A Fernández-Iglesias; L Alonso-Durán; E Rodríguez-Rubio; F Santos
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 7.  Congenital Conditions of Hypophosphatemia Expressed in Adults.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-05-14       Impact factor: 4.333

Review 8.  The investigation of hypocalcaemia and rickets.

Authors:  J Singh; N Moghal; S H S Pearce; T Cheetham
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

9.  Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.

Authors:  Shoji Ichikawa; Amie K Gray; Emmanuel Bikorimana; Michael J Econs
Journal:  Calcif Tissue Int       Date:  2013-05-23       Impact factor: 4.333

Review 10.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.